Skip to main content

GW Kabalka

First name:
GW
Last name:
Kabalka
Hubner, K. ., Thie, J. ., Smith, G. ., Kabalka, G. ., Keller, I. ., Kliefoth, A. ., … Buonocore, E. . (1998). Positron Emission Tomography (PET) with 1-Aminocyclobutane-1- (11)C carboxylic Acid (1- (11)C -ACBC) for Detecting Recurrent Brain Tumors. Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T, 1(3), 165-173. https://doi.org/10.1016/s1095-0397(98)00010-7
Kabalka, G. ., Nichols, T. ., Smith, G. ., Miller, L. ., Khan, M. ., & Busse, P. . (1969). The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma. Journal of Neuro-Oncology, 62(1-2), 187-95. https://doi.org/10.1007/BF02699944 (Original work published 1969)
Nichols, T. ., Kabalka, G. ., Miller, L. ., Khan, M. ., & Smith, G. . (2002). Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography. Medical Physics, 29(10), 2351-8. https://doi.org/10.1118/1.1507780
Kabalka, G. ., Smith, G. ., Dyke, J. ., Reid, W. ., Longford, C. ., Roberts, T. ., … Hubner, K. . (1997). Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 38(11), 1762-7. Retrieved from http://jnm.snmjournals.org/cgi/pmidlookup?view=long&pmid=9374349